avapro has been researched along with Berger Disease in 8 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sixty-two patients diagnosed as IgA nephropathy were randomly divided into control group and treatment group." | 2.71 | [Clinical observation on treatment of IgA nephropathy with Huobahuagen Tablets and irbesartan]. ( Guan, XD; Wu, YF; Zhao, W, 2005) |
| "When indomethacin was added to enalapril treatment, a further significant reduction in urinary proteins and fractional albumin clearance was observed." | 2.69 | The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin. ( Azzollini, N; Mister, M; Perico, N; Remuzzi, A; Remuzzi, G; Ruggenenti, P; Sangalli, F, 1998) |
| "We studied 20 proteinuric patients with IgA nephropathy, who received either enalapril (20 mg/day) or the ANG II receptor blocker irbesartan (100 mg/day) for 28 days in a randomized double-blind study." | 2.69 | ACE inhibition and ANG II receptor blockade improve glomerular size-selectivity in IgA nephropathy. ( Moriggi, M; Perico, N; Remuzzi, A; Remuzzi, G; Ruggenenti, P; Sangalli, F; Vendramin, G, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simeoni, M | 1 |
| Nicotera, R | 1 |
| Pelagi, E | 1 |
| Libri, E | 1 |
| Comi, N | 1 |
| Fuiano, G | 1 |
| Nishida, M | 1 |
| Morimoto, M | 1 |
| Ohno, K | 1 |
| Hamaoka, K | 1 |
| Zeng, J | 1 |
| Wen, Q | 1 |
| Rong, R | 1 |
| Huang, F | 1 |
| Yang, Q | 1 |
| Tang, X | 1 |
| He, F | 1 |
| Huang, N | 1 |
| Yu, X | 1 |
| Ferraro, PM | 1 |
| Ferraccioli, GF | 1 |
| Gambaro, G | 1 |
| Fulignati, P | 1 |
| Costanzi, S | 1 |
| Heras, M | 1 |
| Saiz, A | 1 |
| Pardo, J | 1 |
| Fernández-Reyes, MJ | 1 |
| Sánchez, R | 1 |
| Alvarez-Ude, F | 1 |
| Guan, XD | 1 |
| Wu, YF | 1 |
| Zhao, W | 1 |
| Perico, N | 2 |
| Remuzzi, A | 2 |
| Sangalli, F | 2 |
| Azzollini, N | 1 |
| Mister, M | 1 |
| Ruggenenti, P | 2 |
| Remuzzi, G | 2 |
| Vendramin, G | 1 |
| Moriggi, M | 1 |
4 trials available for avapro and Berger Disease
| Article | Year |
|---|---|
Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: a randomized controlled trial.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl C | 2009 |
[Clinical observation on treatment of IgA nephropathy with Huobahuagen Tablets and irbesartan].
Topics: Adolescent; Adult; Angiotensin II; Biphenyl Compounds; Drug Therapy, Combination; Drugs, Chinese Her | 2005 |
The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflam | 1998 |
ACE inhibition and ANG II receptor blockade improve glomerular size-selectivity in IgA nephropathy.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Co | 1999 |
4 other studies available for avapro and Berger Disease
| Article | Year |
|---|---|
Successful Use of Aliskiren in a Case of IgA- Mesangial Glomerulonephritis Unresponsive to Conventional Therapies.
Topics: Amides; Biopsy, Needle; Drug Administration Schedule; Drug Resistance, Multiple; Drug Therapy, Combi | 2019 |
IgA nephropathy in a girl with mitochondrial disease.
Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biops | 2015 |
Vitamin D-Binding Protein Is a Potential Urinary Biomarker of Irbesartan Treatment Response in Patients with IgA Nephropathy.
Topics: Adult; Biomarkers; Biphenyl Compounds; Blotting, Western; Electrophoresis, Gel, Two-Dimensional; Fem | 2016 |
[Rapidly progressive renal failure as the onset of an IgA nephropathy in an elderly patient].
Topics: Acute Kidney Injury; Adenocarcinoma; Aged; Biphenyl Compounds; Disease Progression; Diuretics; Doxaz | 2011 |